ICU Medical, Inc. (ICUI)

Market Cap	4.36B
Revenue (ttm)	2.30B
Net Income (ttm)	-70.79M
Shares Out	24.43M
EPS (ttm)	-2.93
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131,244
Open	178.32
Previous Close	177.20
Day's Range	177.54 - 180.87
52-Week Range	78.28 - 188.53
Beta	0.66
Analysts	Buy
Price Target	149.00 (-16.54%)
Earnings Date	Nov 4, 2024

About ICUI

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and elimina...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Mar 31, 1992
• Employees: 14,000
• Stock Exchange: NASDAQ
• Ticker Symbol: ICUI
• Website: https://www.icumed.com

Financial Performance

In 2023, ICU Medical's revenue was $2.26 billion, a decrease of -0.92% compared to the previous year's $2.28 billion. Losses were -$29.66 million, -60.08% less than in 2022.

Analyst Forecast

According to 4 analysts, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is $149.0, which is a decrease of -16.54% from the latest price.

Price Target

$149.0

(-16.54% downside)

Analyst Consensus: Buy